Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05157698 · ClinicalTrials.gov registry record · Phase 2

Pharmacological and Behavioral Treatment After Bariatric Surgery

A Phase 2 study of Obesity, sponsored by Yale University.

Recruiting
Registry status
Phase 2
Development phase
160
Enrollment target
1
Study location

NCT05157698 is a Phase 2 study of Obesity that is actively recruiting participants, run by Yale University. The registered enrollment target is 160 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05157698, a Phase 2 study of Obesity, is actively recruiting participants, sponsored by Yale University.

RECRUITING
Registry status
Phase 2
Development phase
160 participants
Enrollment target
1
Study location

Study Summary

This study will compare the effectiveness of behavioral and pharmacologic treatment, alone and combined, for improvements in weight loss, cardiovascular risk factors, and psychosocial functioning following metabolic and bariatric surgery.

Conditions Studied

Obesity

Interventions

  • OTHER Placebo
  • BEHAVIORAL Behavioral Weight Loss
  • DRUG Naltrexone and Bupropion Combination

Study Locations (1)

Connecticut

  • Yale School of Medicine - New Haven

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2022-01-13
Est. Completion 2028-01-12
Phase Phase 2

Sponsor

Yale University

1,492 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05157698

The ClinicalTrials.gov registry entry for NCT05157698 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (80% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT05157698 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT05157698 about?

NCT05157698 is a clinical study titled "Pharmacological and Behavioral Treatment After Bariatric Surgery". This study will compare the effectiveness of behavioral and pharmacologic treatment, alone and combined, for improvements in weight loss, cardiovascular risk factors, and psychosocial functioning following metabolic and bariatric surgery.

What is the current status of trial NCT05157698?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 160 participants. The study started on 2022-01-13. Estimated completion is 2028-01-12.

What conditions does trial NCT05157698 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT05157698?

The interventions under investigation include: Placebo (OTHER), Behavioral Weight Loss (BEHAVIORAL), Naltrexone and Bupropion Combination (DRUG).

Who is sponsoring clinical trial NCT05157698?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05157698 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Obesity

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.